Table 2.
The description of parameters and values.
| Parameter | Description | Value | Source |
|---|---|---|---|
| Recruitment rate of susceptible individuals | [47] | ||
| Infection modification parameter for the asymptomatic infection rate | 0.45 | [48] | |
| Infection modification parameter for the hospitalized infection rate | 0.4509 | [48] | |
| Transmission rate of COVID-19 | 0.5249 | [47] | |
| Transmission rate of influenza | 0.203 | [49] | |
| Vaccination rate against COVID-19 | 0.0203 | [45] | |
| Vaccination rate against influenza | 0.00027375 | [50] | |
| Vaccination rate against COVID-19 and influenza | 0.00027375–0.0203 | Assumed | |
| Immunity waning rate of recovered individuals with COVID-19 | 0.011 | [31] | |
| Immunity waning rate of recovered individuals with influenza | 0.088 | [51] | |
| Immunity waning rate of recovered individuals with co-infection | 0.011–0.088 | Assumed | |
| Vaccine waning rate of COVID-19 | 0.000297 | [47] | |
| Vaccine waning rate of influenza | 0.15 | [51] | |
| Vaccine waning rate of COVID-19 and influenza | 0.000297–0.15 | Assumed | |
| COVID-19 vaccine efficacy | 0.70 | [47] | |
| Influenza vaccine efficacy | 0.77 | [50] | |
| COVID-19 and influenza vaccine efficacy | 0.80 | Assumed | |
| COVID-19 progression rate from the exposed to either | 0.40 | [47] | |
| asymptomatic or symptomatic infectious | |||
| Influenza progression rate from the exposed to infectious | 0.40 | [52] | |
| co-infection progression rate from the exposed to infectious | 0.40 | Assumed | |
| Fraction of COVID-19 exposed individuals becoming symptomatic | 0.60 | [53] | |
| Natural mortality rate | 0.0003516 | [47] | |
| Death due to COVID-19 | 0.008 | [54] | |
| Death due to influenza | 0.021 | [50] | |
| Death due to co-infection | 0.021–0.026 | Assumed | |
| Hospitalization rate of symptomatic infectious individuals | 0.0624 | [33] | |
| Recovery rate of COVID-19 asymptomatic infectious individuals | 0.13978 | [33] | |
| Recovery rate of COVID-19 hospitalized infectious individuals | 0.125 | [47] | |
| Recovery rate of influenza infectious individuals | 0.1998 | [50] | |
| Recovery rate of co-infected infectious individuals | 0.125–0.1998 | Assumed | |
| Reduction of susceptibility to COVID-19 infection | 0.50 | Assumed | |
| Reduction of susceptibility to influenza infection | 0.50 | Assumed |